University of Texas at El Paso

DigitalCommons@UTEP
Open Access Theses & Dissertations

2015-01-01

Restraint Stress Alters Pro-Inflammatory Cytokine
Expression And Increases Superoxide Dismutase In
The Rat Hypothalamus And Hippocampus
Kristina Isabel Barron
University of Texas at El Paso, kibarron@yahoo.com

Follow this and additional works at: https://digitalcommons.utep.edu/open_etd
Part of the Biology Commons, Endocrinology Commons, Endocrinology, Diabetes, and
Metabolism Commons, and the Neuroscience and Neurobiology Commons
Recommended Citation
Barron, Kristina Isabel, "Restraint Stress Alters Pro-Inflammatory Cytokine Expression And Increases Superoxide Dismutase In The
Rat Hypothalamus And Hippocampus" (2015). Open Access Theses & Dissertations. 998.
https://digitalcommons.utep.edu/open_etd/998

This is brought to you for free and open access by DigitalCommons@UTEP. It has been accepted for inclusion in Open Access Theses & Dissertations
by an authorized administrator of DigitalCommons@UTEP. For more information, please contact lweber@utep.edu.

RESTRAINT STRESS ALTERS PRO-INFLAMMATORY CYTOKINE
EXPRESSION AND INCREASES SUPEROXIDE DISMUTASE IN THE RAT
HYPOTHALAMUS AND HIPPOCAMPUS

KRISTINA ISABEL BARRON
Department of Biological Sciences

APPROVED:

Kristin L. Gosselink, Ph.D., Chair

Kristine M. Garza, Ph.D.

Manuel Miranda-Arango, Ph.D.

Sudip Bajpeyi, Ph.D.

Charles Ambler, Ph.D.
Dean of the Graduate School

Copyright ©

by

Kristina Isabel Barron
2015

Dedication

For my parents

RESTRAINT STRESS ALTERS PRO-INFLAMMATORY CYTOKINE
EXPRESSION AND INCREASES SUPEROXIDE DISMUTASE IN THE RAT
HYPOTHALAMUS AND HIPPOCAMPUS

by

KRISTINA ISABEL BARRON, B.S

THESIS

Presented to the Faculty of the Graduate School of
The University of Texas at El Paso
in Partial Fulfillment
of the Requirements
for the Degree of

MASTER OF SCIENCE

Department of Biological Sciences
THE UNIVERSITY OF TEXAS AT EL PASO
August 2015

Acknowledgements
I’d like to thank Dr. Kristin Gosselink for being an incredible mentor. Thank you to
Christina D’Arcy for likewise being an incredible mentor and friend, and the entire Gosselink Lab
for their support and friendship. Special thanks goes to Joanna Gardea and Jameel Hamdan for the
flow cytometry and bead array work. All of you have a special place in my heart forever. Many
thanks go to my committee for their guidance and finally, a great many thanks to my family for
their invaluable support throughout this journey. I could not have done this without you.

v

Abstract
The impact of restraint stress on changes in cytokine expression and oxidative stress
markers in hippocampal (Hipp) and hypothalamic (Hyp) regions of the brain, were assessed in a
rat model. In addition, immune and inflammatory variables were assessed in peripheral blood.
Male Wistar rats were acutely (30 min) or repeatedly (30 min/d for 14 consecutive days) exposed
to a restraint stress, or maintained as non-stressed controls. At the time of sacrifice, whole blood
and brain tissues enriched in Hyp or Hipp regions were collected; blood was collected with EDTA
as an anticoagulant and centrifuged to yield plasma. All tissue samples were frozen at -20°C until
assayed. Plasma samples were evaluated for pro-inflammatory cytokine expression (TNFα, IL-6,
IL-1α, IL-1β) by ELISA to confirm findings previously seen by Milliplex® analysis in separate
groups of a different strain of rats. Hipp and Hyp isolates were homogenized and subjected to the
same cytokine analysis, and were Western blotted to determine expression levels of oxidative
stress markers superoxide dismutase 1 (SOD1) and the receptor for advanced glycation endproducts (RAGE) and insulin degrading enzyme (IDE). Repeated stress increased the expression
of SOD1, and acute and repeated stress decreased levels of IL-1α but increased levels of IL-1β.
TNFα and IL-6 levels remained unchanged regardless of stressor. No other significant differences
were seen. This study provides valuable insight on how stress exposure can alter important
homeostatic functions, and informs possible pathways through which repeated or chronic stress
may affect the incidence or progression of diseases that include inflammatory or oxidative stress
components.
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Introduction
A stress is any stimulus that either offers physiological challenge and a shift from
homeostasis or can be a perceived threat to organismal well-being. Stressors are unpredicted or
unwanted occurrences that can elicit anything from mild emotional irritation to shock.
Furthermore, stress can occur acutely or chronically, each carrying a variation in the response
produced. There are also “positive” stressors, such as exercise, which generally benefit health yet
elicit a response that can vary as greatly as “negative” stressors can. A response to stress is the
organism’s way of adapting to situations to best ensure survival. Exposure to a stressor elicits a
two-pronged response that starts with activation of the sympathetic-adrenal-medullary (SAM)
pathway, also known as the classic “fight or flight” response, and also involves the activation of
the hypothalamic-pituitary-adrenal (HPA) axis. Activation of the SAM excites the autonomic
nervous system, which leads to a release of epinephrine and norepinephrine from nerve terminals
and the adrenal medulla. This increases an organism’s heart and respiratory rate and increases
blood flow to skeletal muscles in order to fight off the stressor or flee from danger. While this first
response pathway is generally short-lived, activation of the second prong of the stress response,
the HPA axis, is slower to initiate and has a more prolonged effect in the body (Cortisol duration
of action < 12 hours, [1]). This secondary response is mediated by glucocorticoids (GC) which act
as transcriptional regulators (slow response) or through membrane bound GC receptors (fast
response) to increase glucose in the blood stream through gluconeogenesis and an increase in the
metabolism of energy sources. GCs also suppress the immune system and other “non-essential”
bodily functions such as food intake or sexual reproduction to prioritize energy while the body
deals with the stressor [2]. Activation of the HPA axis is initiated in the paraventricular nucleus of
the hypothalamus (PVH) through the release of corticotropin-releasing hormone (CRH). CRH then
acts on the anterior pituitary gland to stimulate release of adrenocorticotropic hormone (ACTH),
which stimulates the release of GCs, mainly cortisol (humans) or corticosterone (rodents), from
the adrenal cortex. The HPA axis is regulated through negative feedback loops; cortisol (or
1

corticosterone) inhibits further release of CRH and ACTH while ACTH also acts on the
hypothalamus to inhibit the release of CRH [2, 3].

Illustration i.i: Known stress activation pathways
The central nervous system, endocrine system, and the immune system interact closely
with one another. Dysregulation of one system can have consequences that affect the other two.
Chronic stress has been shown to have adverse effects on the immune system [4-6]. While short
stressors that do not exceed 2 hours can augment the immune response in ways such as increasing
cell trafficking from lymphoid organs to the periphery, stressors are more often damaging. For
example, stressors can increase the production of pro-inflammatory cytokines that lead to
complications involving oxidative stress, memory impairments due to oxidative stress, and other
dysregulatory complications [7, 8]. Memory impairments can result from excitotoxic damage as
stress levels of GCs have been shown to elevate glutamate and diminish neurogenesis [9, 10].
There are various conditions that carry an inflammatory component we believe can be
complicated by stress. Below is a table listing only a few of these conditions:
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Table i.1: Immune responses related to neurodegenerative disease and obesity
Disease

Immune Response



Alzheimer’s Disease



Increase of pro-inflammatory cytokines
Complement components around Amyloid
 plaques
Accumulation of advanced glycation endproducts (AGEs)

Obesity



Increase of pro-inflammatory cytokines

Multiple Sclerosis





Activation of NK cells and microglia
Accumulation of AGEs
AGE receptor (RAGE) activation induced
oxidative stress

**Items highlighted in red correspond to the primary objective of this thesis.
As life-expectancy increases around the world, and increases in age-related disease, such
as Alzheimer’s, become more prevalent, there is a push to examine how stress can alter our
propensity for these diseases in various ways.
The goal of this thesis project is to examine how emotional stress alters oxidative stress
mechanisms in the brain and immune system components alone in order to predict how these
changes can potentially alter the body’s prevalence for neurodegenerative age related diseases.
This information can also be used to identify the importance of new or emerging treatments for
disease as stress is now a normal component of everyday life. This thesis project will examine
the potential for stress-induced changes in the hypothalamus and hippocampus of the brain as the
hypothalamus is the region associated with the stress response, and the hippocampus is
associated with learning and memory –an important region when discussing neurodegenerative
disease. The project will also investigate the changes associated with stress and cytokine
expression in the same regions and in the periphery, as well as white blood cell populations, to
identify the potential for stress-induced inflammation which can further complicate any disease.
Currently, there exists much information on the effects of GCs on oxidative stress mechanisms in
3

the brain but an investigation on how stress alone affects proteins associated with the clearance
of oxidative stress has yet to be done. Furthermore, studies exists investigating the changes
associated with cytokine expression after stress in regards to wound healing and the clearance of
pathogens but there is a lack of information to show whether changes in cytokine expression
occur in the hypothalamus and hippocampus and if changes in the periphery match changes seen
in other studies. There is also little information on changes in white blood cell populations in
response to stress. Throughout the study, references to the effects of stress on obesity will be
mentioned as obesity is considered a pro-inflammatory state and is one of the diseases the
information gathered here may be of influence in treating.
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Chapter 1: Oxidative Stress
1.1

POTENTIAL FOR OXIDATIVE STRESS
It is known that increases in GCs are related to increases in reactive oxygen species (ROS)

[11]. There is also a correlation between stress and induced increases of nitric oxide synthase,
although this is NFkB dependent [12]. There have been several studies comparing markers of
oxidative stress in animals that are obese but a lack of information exists when looking at
physiological stressors alone. In obese rats, levels of reactive oxygen species are increased
compared to controls [13-15].
The receptor for advance glycation end-products (RAGE) is implicated in oxidative stress
during periods of hyperglycemia and contributes to the idea of obesity being an inflammatory state
of being [16]. RAGE has been found to traffic amyloid beta across the blood brain barrier [17]
which is the primary pathology of Alzheimer’s disease. As obesity is considered a state of systemic
inflammation, understanding the role of stress in this system could provide valuable insight.
However, it is not entirely understood how stress affects expression of SOD1 and RAGE alone
and to what extent obesity together with stress complicates the issue.
1.2

DYSFUNCTION IN HYPOTHALAMUS
Dysregulation of the HPA axis due to stress has long been established [18, 19].

While stress is normally associated with an increase in GC production, additional evidence
supports a role for chronic stress in diminishing HPA axis responsiveness. Diminished activity is
attributed to a repetitive homotypic stressor - a stressor to which an organism habituates. However,
diminished activity of the HPA axis is also seen in adult animals that experienced chronic neonatal
stress [19], suggesting that these types of adaptations can be long-lasting and modification of HPA
axis activity can result from numerous types of inputs. Other physiological stressors prevalent in
modern society include diseases, such as depression, whose pathology can include abnormal levels
5

of circulating cortisol and HPA axis dysregulation [8]. Other illnesses correlated with
dysregulation of this axis include chronic pain diseases like fibromyalgia which can mask reduced
HPA axis activity making it more difficult to diagnose and treat these illnesses [20]. There is
evidence to suggest that illnesses like depression contain an inflammatory component as well [21].
1.3 DYSFUNCTION IN THE HIPPOCAMPUS
The highest affinity receptors for GC are mineralocorticoid receptors (MR). In the brain,
the highest density of these receptors are found in the hippocampus, the region associated with
memory and learning. GCs have been shown to regulate long term potentiation (LTP) and long
term depression (LTD) within the hippocampus.

http://employees.csbsju.edu/ltennison/PSYC340/learning.htm

Illustration 1.1: Diagram of Long-term Potentiation
The phenomena of LTD and LTP are critical for memory formation and retention. High MR
receptor binding with low glucocorticoid receptor (GR) binding can result in an increase in
cognitive performance. However, GC concentrations outside of these levels worsens LTP [22].
During normal circadian cycles, peak cortisol release occurs in the morning hours and binds 90%
of MR receptors and around 10% of GR receptors. During stress, MR receptors become saturated
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and GR receptor binding increases to approximately 67-74% [23]. Activation of MR receptors
showed enhancement and prolongation of LTP and the opposite was seen with high activation of
GR receptors [24]. GC levels within the range of basal and stressed individuals are best for
reaching optimal LTP. Binding of MR receptors during basal, non-stressed conditions suppresses
serotonin-receptor related activity attenuating the cellular response to serotonin receptor binding
in the hippocampus. During stress, increased GR receptor binding alongside saturated MR
receptors shows increased hippocampal responsiveness to serotonin receptor activation and
attenuated auto-inhibition of serotonin. Chronic exposure to high levels of GR receptor binding
leads to impaired serotonin neurotransmission [25]. High levels of GCs are correlated with
increased levels of glutamate which further damage neuronal cells through excitotoxicity [9].
There is also evidence to suggest GCs decrease the ability of glutathione peroxidase to remove
superoxides in the hippocampus, and that GC treatment lowers the activity of superoxide
dismutase ex vivo in male Sprague-Dawley rats [11].
The aim of this portion of the project was to identify the changes in markers of
oxidative stress and the expression of known obesity affected proteins in the hypothalamic
and hippocampal regions of the brain in response to stress. It was hypothesized that markers
for oxidative stress in key regions of the brain will be altered in response to repeated
emotional stress.
1.4

METHODS
1.4.1

Animals

Adult male Wistar rats were used for these studies due to their propensity for heightened
responses when presented with an immune challenge [26]. Rats were singly housed in a light- and
temperature-controlled vivarium on a 12:12h light cycle. Food and water were provided ad
libitum, with the exception of the short periods of time in which the animals were exposed to stress
(see below). All animal procedures were done in accordance with the Guide to the Care and Use
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of Laboratory Animals, and following approval by UTEP’s Institutional Animal Care and Use
Committee.
1.4.2

Stress Paradigm
Table 1.1: Stress Paradigm used for experimentation

Treatment

Duration of stress

Timing

Control

0 minutes

Acute

30 minutes

30 minute exposure only, 14
days
1 time on day 14

Repeated

30 minutes

daily for 14 days

Restraint was done using an acrylic half-cylinder restrainer designed with slits for ventilation (Kent
Scientific, Torrington, CT) within their home cages. Control rats were exposed to the restrainers
every day for 14 days but never placed into the restrainer to be stressed. All restraint sessions were
initiated near the beginning of the light cycle (0900 h).
1.4.3

Tissue Harvest

At the end of each experiment, rats were weighed and deeply anesthetized by i.p. injection
of 100 mg/kg sodium pentobarbital (Sigma, St. Louis, MO). Whole brains were dissected from the
skull, blocked to isolate regions of interest, and frozen on dry ice until used for the analyses
outlined below.
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1.4.4

Western Blotting

Illustration 1.2(a): For all animals, harvested and blocked brain tissues were slowly thawed and
dissected as depicted above to yield Hipp- and Hyp-enriched regions.

Illustration 1.3: The hippocampal and hypothalamic regions were isolated
Illustration 1.2(b): Hipp and Hyp regions were isolated by making the cuts illustrated above.
Homogenates were prepared from the hypothalamic and hippocampal areas by
homogenization in 1 mL Tissue Protein Extraction Reagent (T-PER®, Thermo Scientific™) with
10uL of Halt™ Single-Use protease inhibitor cocktail (Thermo Scientific™). The samples were
centrifuged at 5000 rpm for 5 min and the supernatant saved. A Bicinchoninic Acid assay kit
(Thermo Scientific™) was used to determine the concentration of total protein in each sample
prior to Western blotting or Milliplex analysis. Samples were divided into 20uL aliquots and frozen
at -20°C to prevent multiple freeze-thaw cycles. Prior to western blotting, samples were prepared
9

with 2X sample buffer to a final concentration of 18g/mL protein. Samples were heated for 5 min
at 100°C prior to loading on a 10-20% gradient gel (BioRad) and separated by SDS-PAGE for 20
minutes at 80V (to pass through the stacking gel) and then at 120V for ~1 hour and 10 minutes.
Proteins were transferred onto a PVDF membrane by wet transfer (16 hours, 200mA). Membranes
were blocked for 60 minutes to prevent non-specific binding in 1% BSA in 1X TBS with 0.05%
Tween20 (1X TBST) at room temperature, then reacted with primary and secondary antibodies to
identify specific protein bands as follows:
Table 1.2: Antibodies used along with concentrations and animal of origin
Primary

Created in

Concentration

Secondary Antibody

Concentration

Rabbit

1:2000

Goat anti Rabbit

1:2000

Rabbit

1:1000

Goat anti Rabbit

1:2000

Mouse

1:1000

Goat anti Mouse

1:2000

Mouse

1:2000

Goat anti Mouse

1:2000

Antibody
SOD1
~17kD
RAGE
~45 kD
IDE
~118kD
Actin
~42kD

Primary antibodies were diluted in Blocking buffer (1% BSA in 1X TBST) and used overnight at
4○ C. Alkaline phosphatase-conjugated secondary antibodies (diluted in blocking buffer) were
applied to the blots for 1 hour at room temperature and the blots developed using a
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chemiluminescent agent (BioRad) with variable times of exposure on photographic film. Films
were scanned and densitometry performed using LabWorks software.
1.5

RESULTS
Actin

SOD1

128 A

129 C

130 A

131 C

132 A

144 R

145R

146 R

Illustration 1.4: Western blot of SOD1 and Actin (loading control) in Hippocampus labeled with
animal number and treatment. “A” represents Acute, “C” is for Control, and “R” is
for Repeated.
P e r c e n t c h a n g e o f S O D 1 in H ip p o c a m p u s
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Figure 1.1: Expression of SOD1 in hippocampus of the rat brain trends towards increasing in
response to acute and repeated stress. Each value is the mean of percentage values
for 3 blots. A total of 8 animals were used, 2 control, 3 acute, and 3 repeated. P
values were determined by Student’s T-Test.
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Percent change of SOD1 in Hypothalamus
140

p=0.18

120

p=0.95

Percentage

100
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0
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Treatment

Figure 1.2 Expression of SOD1 in hypothalamus of the rat brain trends towards increase in
response to repeated stress. Values are the result of a single blot of 8 animals, 2
control, 3 acute, and 3 repeated, plus SEM. (Student’s T-test acute p=0.95, repeated
p=0.18).

Figure 1.1 depicts the percent change in SOD1 expression in hippocampus when compared
to control animals. The figure is representative of 3 blots. Each blot consisted of 2 control animals,
3 acutely stressed animals, and 3 repeatedly stressed animals. SOD1 expression was shown to be
increased, though not significantly, after restraint stress both acute and repeated (Student’s T-test
p=0.68 and p=0.90, respectively).
Figure 1.2 illustrates the percent changes of SOD1 in the hypothalamus when compared to
control animals. The figure is representative of a single blot consisting of 2 control animals, 3
acutely stressed animals, and 3 repeatedly stressed animals. The graph shows a trend towards
increasing of SOD1 in acutely and repeatedly stressed rats although the increases cannot be
measured statistically owing to the lack of replicates.
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1.6

FUTURE DIRECTIONS
A novel model of obesity would use the data generated from this project to investigate how

stress affects the same parameters as above with the added complication of obesity, an
inflammatory state. These future experiments would also include the effects of stress on insulin
degrading enzyme (IDE) and insulin receptor  (IR) alone. After obtaining the baseline of how
stress alone affects expression of these proteins in the hippocampus and hypothalamus, we can
investigate how it changes in obese and/or diabetic rats. Some insight into what can occur is
provided in the figure below:

Percent change of IDE in hippocampus
180

p=0.12

160

Percentage

140

p=0.87

120
100
80
60
40
20
0
Control

Acute

Repeated

Treatment

Figure 1.3 Expression of IDE in hippocampus trends toward increase after repeated stress. This
graph represents a single blot consisting of 2 control animals, 3 acutely stressed
animals, and 3 repeatedly stressed animals plus SEM. (Student’s T-test, repeated
p=0.12, acute p=0.87).
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Chapter 2: Disruption of immune system components
2.1

OXIDATIVE STRESS COMPONENT
The immune system has the potential to be dysregulated by stress through a number of

mechanisms. The stress hormones produced by the HPA or SAM axes have receptors on most
immune cells. This can be problematic in one of two ways. The hormones can modify cellular
activity through direct binding onto the receptors available on the cells or can dysregulate cytokine
production which in turn modifies immune cell function. It has been shown that IL-1 can influence
the production of CRH, activating the stress response and increasing levels of stress hormones that
further dysregulate the immune system. Some lymphocytes also produce ACTH, though the role
of this function is poorly understood [27]. Restraint stress has also been shown to alter viral
immune responses in mice by changing the kinetics of antibody responses and suppressing
cytokine responses both in pro-inflammatory cytokines and anti-inflammatory cytokines [6].
Restraint stress also significantly reduced the size of draining lymph nodes in these mice and cell
trafficking to the lungs of infected mice was also reduced. Blocking of glucocorticoid receptors
(GR) with pharmacological agents restored T cell responses of virus-infected mice as well [6].
Other studies have shown that social stress increases pro-inflammatory cytokines in mice injected
with lipopolysaccharide [28]. It is known that stress delays wound healing and prolongs infection
[5]. A potential mechanism for this likely involves the observations that the release of GCs from
the HPA axis during a stress response suppresses differentiation and proliferation, affects gene
transcription regulation, and reduces cell adhesion molecules necessary for immune cell
trafficking. Decreased concentrations of IL-1α and IL-8 at wound sites are found in women with
high levels of perceived stress. Mouse and rat models of stress corroborate human findings and
can be successfully used as a substitute for human subjects. Stress induced cortisol is assumed to
reduce wound healing by 27% compared to normal non stressed controls when assessed by lack
of foaming at the wound site when hydrogen peroxide was applied. Treatment with a cortisol
antagonist returns wound healing to near normal rates [4]. WBC trafficking to the wound area is
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depleted in stressed animals which is suspected to play a role in the decrease of wound healing
rate [5].
2.2

HOW HPA AXIS ACTIVATION MAY ELICIT CHANGES IN THE IMMUNE SYSTEM
Lymphocytes and monocytes express CRH receptors [29-32] as do murine splenocytes [33,

34] suggesting that CRH plays a role in modulating inflammatory conditions. In vitro, CRH has
been seen to stimulate B cell and T cell proliferation in the presence of IL-2 [32]. There is also
evidence to support the idea that CRH helps control inflammation, and GCs help to dampen the
immune response [35-37]. ACTH can potentially affect B cells to reduce antibody production [38].
ACTH has also been shown in vitro to increase differentiation and growth of B cells in human
tonsils by as much as threefold the original concentration. Furthermore, secretion of Ig by B cells
was increased twofold when ACTH was added to the culture along with IL-2 in a similar way to
CRH. ACTH alone did not enhance Ig secretion suggesting the cytokines might be necessary for
crosstalk between the immune system and the stress response as opposed to it being mediated by
immune cell receptors for GCs or hormones alone [29]. It is therefore the aim of this portion of
the study to identify what changes, if any, occur in cytokine expression in the hippocampus
and the hypothalamus as well as the periphery in response to stress. It is also of interest to
determine if stress alters the amount of white blood cells in circulation. It is hypothesized that
repeated exposure to emotional stress will increase the body’s baseline levels of proinflammatory cytokines due to oxidative stress and that circulating white blood cells will also
be increased due to CRH.
2.3

METHODS
2.1.1

Stress Paradigm

See section 1.1.2
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2.1.2

Blood Collection

Whole blood was collected by cardiac puncture, using an 18G x 1.5” needle attached to a
10mL syringe containing ~250-300uL of 100mg/mL EDTA (0.5 M, pH 7.5). Blood samples were
transferred to 15mL conical tubes, gently inverted to distribute the EDTA and prevent clotting,
and placed on ice until stored at 4°C for a short time or immediately processed for flow cytometry.
Centrifugation of other blood samples (3000 rpm x 30 min at 4°C) yielded plasma for cytokine
analysis.
2.1.3

Cytokine Analysis

Analysis of a panel of cytokines was done on rat plasma samples, as well as the brain
homogenates from hippocampus and hypothalamus.

Cytokines were quantified using the

Millipore MILLIPLEX® MAP Rat Cytokine/Chemokine Panel which simultaneously quantifies
levels of multiple molecules; in our studies, we measured TNFα, GM-CSF, IFNɣ, IL1α, IL-1β, IL2, IL-4, IL-6, IL-10, and IL-12 from small (25L) samples of plasma. The kit uses color coded
microspheres to designate the panel of cytokines chosen and are conjugated to capture antibodies
specific to single cytokines. Secondary antibodies with a fluorescent reporter signal allow for
quantification. The results of the MILLIPLEX® assay were used to narrow down potential
candidates for further analysis. The cytokines that show a significant difference in concentration
compared to control samples were verified by ELISA.
2.1.4

Flow Cytometry

Whole blood was separated using a ficol gradient (Histopaque®, Sigma-Aldrich). 3mL of
blood was centrifuged at 200g for 15min. If more blood than 3mL of blood was present in a single
sample, the sample was spun through the ficol 3mL at a time and then centrifuged to collect the
buffy coats and were pooled. Following this, each sample was spun for 5 minutes at 1200 rpm in
FACS buffer (850mL deionized water, 100mL 10X PBS, 20mL FBS, 1mL 5mM EDTA, 5g of Na
Azide). Supernatant was decanted and the pellet was blocked in 50uL of Mouse IgG. Cells were
re-suspended and placed in a FACS tube and primary antibodies were added (50uL of master mix
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that had 1L of primary antibody per 49L of FACS buffer. Cell were incubated on ice for 45
minutes then each FACS tube was filled with FACS buffer, spun for 5min at 1200 RPM, decanted
and blotted and had 300uL of 4% paraformaldehyde added.
RESULTS

2.4
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Figure 2.1: TNFa (A) and IL-6 (B) expression are unchanged in stressed animals when
compared to unstressed controls. Changes in IL-1 (A) potentially decrease and
changes in IL-1 (B) potentially increase in response to acute and repeated stress
compared to unstressed control when evaluated by Milliplex® analysis. Each graph
represents the average of 3 animals in replicate plus SEM.
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Figure 2.2: IL-1 remains mainly unchanged in response to acute stress while IL-1 trends
towards increase after acute and repeated stress. Graph A represents 3 control and 1
acute animal in replicate, while graph B represents 2 animals per group in replicate
plus SEM.

Figure 2.3: CD2+ cell counts appear to be unaffected by acute stress while CD25+ cells numbers
trend towards decrease. Each measure represents 5 animals per group plus SEM.
(Student’s T-test values p=0.88 and p=0.06, respectively).
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Figure 2.1 depicts the expression of TNF (A), IL-6 (B), IL-1 (C), and IL-1 (D) in the
hippocampus, hypothalamus, and plasma of rats after acute stress. Each measure was obtained
from 3 animals per treatment in duplicate. Student’s T-test obtained p values as follows: TNF
acute plasma p=0.97, hippocampus p=0.27, hypothalamus p=0.75, IL-6 acute plasma p=0.10,
hippocampus p=0.77, hypothalamus p=0.33, IL-1 acute plasma p=0.13, hippocampus p=0.54,
hypothalamus p=0.54, IL-1 acute plasma p=0.97, hippocampus p=0.19, hypothalamus p=0.34.
Figure 2.2 illustrates the expression of IL-1 (A) in plasma of acutely stressed rats. The
graph represents 3 control animals and 1 acutely stressed animal in duplicate done by ELISA.
Figure 2.2 (B) depicts the expression of IL-1 in plasma of acutely and repeatedly stressed rats.
Each group represents 2 animals in duplicate (Student’s T-test acute p=0.24, repeated p=0.25).
Figure 2.3 shows the changes in CD2+ and CD25+ cell numbers in whole blood after acute
stress. CD2+ cells were largely unchanged from control amounts (p=0.884) while the decrease in
CD25+ cells was almost significant with a p-value of 0.06.
2.5

FUTURE DIRECTIONS
Check interaction of CD2+ and CD25+ expressing immune cells as well as markers that

will separate the CD2+ cells into their subpopulations. It would also be interesting to find out if
there is any change in the secretion of antibodies due to the depletion of B cells.
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Discussion
The purpose of this study was to examine the experience of emotional stress has the ability
to alter immune/inflammatory molecules in the brain and in the periphery, or to affect oxidative
stress states in the brain. Many diseases show dysregulations in these systems, and stress is known
to contribute to diseases ranging from cardiovascular to neurological to immune. Understanding
the relationship between stress and the biochemistry of the brain and body is important for disease
prevention, and may help us identify possible targets for treating disease.
The regions of the brain that were examined include the hippocampus (Hipp) and the
hypothalamus (Hyp) – regions of interest to our laboratory that are involved in cognitive
performance and stress and endocrine regulation, respectively. Both of these regions also have
disrupted function in conditions such as Alzheimer’s disease or obesity and type 2 diabetes.
Changes in oxidative stress or inflammatory cytokine levels in these areas have the potential to
significantly impact memory, metabolism and other critical health-related outcomes.
In this thesis project, I examined two proteins that play important roles in oxidative stress:
superoxide dismutase 1 (SOD1) and the receptor for advanced glycation end-products (RAGE). I
determined whether the expression of these proteins was affected by acute or repeated restraint
stress in the Hipp and/or Hyp of adult male rats. Overall, there appears to be an increase, although
not statistically significant, in the expression of SOD1 in repeatedly stressed animals in the
hippocampus and in the hypothalamus compared to unstressed controls. However, the change is
more pronounced in the hypothalamus. This is in contrast to the effects seen in adrenalectomized
rats treated with exogenous GCs [14]. It could indicate a protective measure against superoxides
produced in response to repeated restraint stress [14].
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Although this increase was not statistically significant, it may be physiologically relevant.
Isoforms of SOD belong to the anti-oxidant scavenging pathways that include glutathione
peroxidase, catalase, and glutathione reductase. These enzymes are believed to protect the brain
from damaging reactive oxygen species [39]. SOD1 provides neuronal protection by eradicating
reactive oxygen species [39]. In response to exogenous addition of glucocorticoids (GCs), the
activity of this protein has been shown to decrease [11] but results from the current study show
that restraint stress could potentially increase its expression. The implications of this are interesting
in terms of how we treat disease that is complicated by the presence of ROS. A role for
glucocorticoid antagonists could be indicated in the treatment of these diseases. To complicate the
matter further, changes in RAGE could be especially hazardous given that it can traffic amyloidβ across the blood brain barrier [40].
Another interesting issue is how stress is able to modify integral parts of the
immune system. Cytokines are the main component of communication between cells of the
immune system so anything that can affect them can disrupt communication and alter the
immune response needed for illnesses ranging from something as simple as seasonal allergies to
something more extreme. Of the many types of cytokines, we investigated some in the proinflammatory category. Prior research has indicated that stress can alter immune responses in
terms of wound healing [5] and antibody production [6]. The family of IL-1 cytokines are mainly
pro-inflammatory [41]. These cytokines are secreted early in the immune response by white
blood cells and stimulate the dilation of capillaries and their permeability. They also stimulate
the increase of white blood cell traffic to the area. IL-1 is also known to act on the hypothalamus
to cause fever or as part of regulatory feedback loop to stimulate the production of GCs [41].
While Plasma levels of IL-1α are increased, levels of this cytokine is decreased in the
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hippocampus and hypothalamus. GCs have anti-inflammatory effects which can act to inhibit the
production of IL-1 and TNF. Figure C could be indicative of such a response. However,
levels of Il-1β are increased in response to stress in plasma, hippocampus, and hypothalamus.
Levels of IL-1 and IL-1 are also confirmed by preliminary ELISA data (Figure 2.2). IL-1β
and IL-1α serve the same functions. The difference between them is that IL-1β requires more
processing in its pro form in order to be active whereas pro-IL-1α is biologically active [41].
This could indicate why the dampening response of GCs occurs more quickly for IL-1α as
opposed to IL-1β and can also explain the differences in expression seen in figures 2.1 C and 2.1
D. Our findings show a correlation between restraint stress and alterations in pro-inflammatory
cytokines in the periphery. Adverse levels of cytokines can complicate diseases that are already
considered to be inflammatory states like diabetes and obesity. It could also imply that high
cytokine levels in these already pro-inflammatory states may benefit from GC antagonist
treatment.
In response to stress, there was no change in CD2+ T cells [which include regulatory T
cells, natural killer cells, and cytotoxic T cells] [42]. There was a decrease in cells that are CD25+
which can include activated regulatory T cells (Tr), and activated mature B cells that are ready to
proliferate upon IL-2 stimulation [43, 44]. Depletion of Tr cells could contribute to and increase
the pro-inflammatory response given that Tr cells have inactivation capabilities towards activated
T cells. However, since there was no change in the number of cells expressing CD2 this assumption
can most likely be ignored. Given this, we can conclude the CD25+ cells are most likely not T
cells and may be B cells. In this case, depletion of B cells can contribute to the anti-inflammatory
hypothesis as they are primarily responsible for creating antibodies.
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Increased stress can therefore pose a serious challenge to those attempting to manage
their illness, both in terms of the psychological impact of stress and the biological responses to it.
Combined with the changes stress can effect in oxidative stress, changes in pro-inflammatory
cytokine levels can further disrupt the body’s physiology or can be a marker for existing stress
that can be treated with GC antagonists. It is of great importance to investigate how stress alters
other systems alone in order to fully understand its role in disease and how best to treat it,
especially in light of the fact that stress is so prevalent in our society.
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Conclusions
A trend of increasing expression of SOD1 is seen in hypothalamus and hippocampus of
rats after repeated restraint stress. Restraint stress does not affect expression of TNF or IL-6 in
the hypothalamus, hippocampus, or plasma of rats however, IL-1 trends toward decreasing and
IL-1 could potentially be increased in these regions.
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